Comparison of ENGBD and PTGBD in Acute Suppurative Cholecystitis
Sponsored by Hepatopancreatobiliary Surgery Institute of Gansu Province
About this trial
Last updated 6 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Ended 6 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
* Acute suppurative cholecystitis
* Who can not tolerate or unsuitable for cholecystectomy
Exclusion Criteria
* Unwillingness or inability to consent for the study
* Coagulation dysfunction (INR> 1.5) and low peripheral blood platelet count (<50×10^9 / L) or using anti-coagulation drugs
* Bile duct stones
* Prior surgery of Bismuth Ⅱ, Roux-en-Y and Cholangiojejunostomy
* Preoperative coexistent diseases: acute pancreatitis, GI tract hemorrhage or perforation, severe liver disease(such as decompensated liver cirrhosis, liver failure and so on), septic shock
* Any malignant
* Pregnant women or breastfeeding
